Clustered de novo start-loss variants in GLUL result in a developmental and epileptic encephalopathy via stabilization of glutamine synthetase.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
04 Apr 2024
Historique:
received: 19 12 2023
revised: 05 03 2024
accepted: 06 03 2024
pmc-release: 04 10 2024
medline: 8 4 2024
pubmed: 6 4 2024
entrez: 5 4 2024
Statut: ppublish

Résumé

Glutamine synthetase (GS), encoded by GLUL, catalyzes the conversion of glutamate to glutamine. GS is pivotal for the generation of the neurotransmitters glutamate and gamma-aminobutyric acid and is the primary mechanism of ammonia detoxification in the brain. GS levels are regulated post-translationally by an N-terminal degron that enables the ubiquitin-mediated degradation of GS in a glutamine-induced manner. GS deficiency in humans is known to lead to neurological defects and death in infancy, yet how dysregulation of the degron-mediated control of GS levels might affect neurodevelopment is unknown. We ascertained nine individuals with severe developmental delay, seizures, and white matter abnormalities but normal plasma and cerebrospinal fluid biochemistry with de novo variants in GLUL. Seven out of nine were start-loss variants and two out of nine disrupted 5' UTR splicing resulting in splice exclusion of the initiation codon. Using transfection-based expression systems and mass spectrometry, these variants were shown to lead to translation initiation of GS from methionine 18, downstream of the N-terminal degron motif, resulting in a protein that is stable and enzymatically competent but insensitive to negative feedback by glutamine. Analysis of human single-cell transcriptomes demonstrated that GLUL is widely expressed in neuro- and glial-progenitor cells and mature astrocytes but not in post-mitotic neurons. One individual with a start-loss GLUL variant demonstrated periventricular nodular heterotopia, a neuronal migration disorder, yet overexpression of stabilized GS in mice using in utero electroporation demonstrated no migratory deficits. These findings underline the importance of tight regulation of glutamine metabolism during neurodevelopment in humans.

Identifiants

pubmed: 38579670
pii: S0002-9297(24)00078-8
doi: 10.1016/j.ajhg.2024.03.005
pmc: PMC11023914
pii:
doi:

Substances chimiques

GLUL protein, human EC 6.3.1.2
Glul protein, mouse EC 6.3.1.2
Glutamate-Ammonia Ligase EC 6.3.1.2
Glutamates 0
Glutamine 0RH81L854J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

729-741

Informations de copyright

Copyright © 2024 American Society of Human Genetics. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Cell. 2022 Nov 10;185(23):4428-4447.e28
pubmed: 36318921
J Neurochem. 2006 Aug;98(3):641-53
pubmed: 16787421
Med. 2022 Nov 11;3(11):792-811.e12
pubmed: 36108629
Mol Cell. 2016 Mar 17;61(6):809-20
pubmed: 26990986
Nature. 2018 Sep;561(7721):63-69
pubmed: 30158707
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Int J Mol Sci. 2018 Apr 12;19(4):
pubmed: 29649168
Am J Hum Genet. 2021 May 6;108(5):857-873
pubmed: 33961779
Clin Genet. 2018 Dec;94(6):538-547
pubmed: 30280376
Neuron. 2006 Mar 16;49(6):823-32
pubmed: 16543131
Neuron. 2020 Mar 4;105(5):867-881.e9
pubmed: 31883789
Neurotherapeutics. 2010 Oct;7(4):452-70
pubmed: 20880508
Expert Opin Ther Targets. 2017 May;21(5):461-469
pubmed: 28292200
Am J Hum Genet. 2016 Oct 6;99(4):802-816
pubmed: 27616483
Neuron. 2014 Feb 19;81(4):814-29
pubmed: 24559674
N Engl J Med. 2005 Nov 3;353(18):1926-33
pubmed: 16267323
Neuron. 2021 Feb 3;109(3):408-419
pubmed: 33306962
Rev Endocr Metab Disord. 2010 Sep;11(3):171-8
pubmed: 20936362
Metab Brain Dis. 2014 Dec;29(4):983-9
pubmed: 24136581
Genet Med. 2019 Jan;21(1):102-106
pubmed: 29884839
Hum Mol Genet. 2019 Jan 1;28(1):96-104
pubmed: 30239721
NMR Biomed. 2013 Dec;26(12):1630-46
pubmed: 24123328
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Biology (Basel). 2016 Oct 19;5(4):
pubmed: 27775558
Exp Mol Med. 2020 Sep;52(9):1496-1516
pubmed: 32943735
Science. 2015 Mar 27;347(6229):1465-70
pubmed: 25721503
Nutrients. 2019 Jul 19;11(7):
pubmed: 31330962

Auteurs

Amy G Jones (AG)

Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Matilde Aquilino (M)

Neuroscience Center, HiLIFE - Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

Rory J Tinker (RJ)

Vanderbilt University Medical Center, Nashville, TN, USA.

Laura Duncan (L)

Center for Individualized Medicine, Mayo Clinic, Jacksonville, FL, USA.

Zandra Jenkins (Z)

Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Gemma L Carvill (GL)

Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Stephanie J DeWard (SJ)

GeneDx, Gaithersburg, MD, USA.

Dorothy K Grange (DK)

Washington University, St. Louis, Missouri, USA.

M J Hajianpour (MJ)

Albany Medical College, Albany, NY, USA.

Benjamin J Halliday (BJ)

Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Muriel Holder-Espinasse (M)

Department of Clinical Genetics, Guys Hospital, London, UK.

Judit Horvath (J)

Münster University Hospital, Münster, Germany.

Silvia Maitz (S)

Medical Genetics Service, Oncology Department of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

Vincenzo Nigro (V)

Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Naples, Italy.

Manuela Morleo (M)

Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Naples, Italy.

Victoria Paul (V)

Münster University Hospital, Münster, Germany.

Careni Spencer (C)

Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Department of Medicine, Division of Human Genetics, Groote Schuur Hospital, Cape Town, South Africa.

Alina I Esterhuizen (AI)

Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Neuroscience Institute, University of Cape Town, Cape Town, South Africa; National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.

Tilman Polster (T)

Department of Epileptology (Krankenhaus Mara, Bethel Epilepsy Center) Medical School OWL, Bielefeld University, Bielefeld, Germany.

Alice Spano (A)

Maggiore Della Carità Hospital, Novara, Italy.

Inés Gómez-Lozano (I)

Neuroscience Center, HiLIFE - Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

Abhishek Kumar (A)

Centre for Protein Research, University of Otago, Dunedin, New Zealand.

Gemma Poke (G)

Genetics Health Service New Zealand, Wellington Hospital, Wellington, New Zealand.

John A Phillips (JA)

Vanderbilt University Medical Center, Nashville, TN, USA.

Hunter R Underhill (HR)

University of Utah, Salt Lake City, UT, USA.

Gregory Gimenez (G)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Takashi Namba (T)

Neuroscience Center, HiLIFE - Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

Stephen P Robertson (SP)

Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. Electronic address: stephen.robertson@otago.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH